SCALE-UP: Meet the Buyer event in Mechelen
March 29 @ 12:30 am - 2:30 pm
In order to achieve better biodegradability of its products, Beaulieu International Group is looking for suppliers of polymers that are biodegradable in natural conditions (soil, water, etc.).
Beaulieu International Group is a chemical and manufacturing company active in 16 countries. The group employs 4,400 people and realised an annual revenue of 1.8 billion euro in 2015. The headquarter is located in Belgium.
Innovation and needs of our buyer
The polymer should have a high tensile strength (preferably > 30 Mpa according to ISO527). The polymer is preferably available as granules, and future production volumes should be large industrial volumes.
See the buyer profile for more information on the innovation and buying needs of Beaulieu.
How to participate?
The Meet the Buyer event is invite only. Matched companies will have 1-on-1 meetings (30 min.) with Beaulieu. Get in touch with us and we’ll introduce your company profile to Beaulieu. Based on their review you can be selected to participate in the Meet the Buyer event.
For more information, please contact Kristin Adriaensen, i-Cleantech Vlaanderen,
Scale-Up is a collaboration with clean tech cluster from the Netherlands, England, Belgium, Denmark and Sweden, with its initiator the municipality of Rotterdam and Clean Tech Delta. Through this program, large companies will be helped to ﬁnd more green products and buy them from innovators. At the same time, young and, yet, small companies are enabled to grow and to make the economy more sustainable. Scale-up is funded by the European Development Fund Interreg.
This event is a great opportunity for the companies to meet large buyers across Europe. Moreover, parallel to the M.T.B. events there will be a regular networking event, giving the start-ups the chance to meet companies in NL and Belgium.
Attending the events is free! Furthermore, the start-ups/ SMEs can reimburse 50% of their traveling costs up to €250.
For more information please contact ICN.